Direct oral anticoagulants in gastrointestinal malignancies: is the convenience worth the risk?

被引:10
|
作者
Thapa, Namisha [1 ]
Shatzel, Joseph [2 ]
Deloughery, Thomas G. [2 ]
Olson, Sven R. [2 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Med, Knight Canc Inst, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, Portland, OR 97201 USA
关键词
VENOUS THROMBOEMBOLISM;
D O I
10.21037/jgo.2019.02.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:807 / 809
页数:3
相关论文
共 50 条
  • [21] When to Resume Direct Oral Anticoagulants Following Gastrointestinal Bleeding
    Kyaw, Moe H.
    Chan, Francis K. L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (12) : 1870 - 1871
  • [22] Up and down in gastrointestinal cancer and bleeding with direct oral anticoagulants
    Martin, Andres J.
    Alsar, Javier Soto
    Moran, Laura Ortega
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 127 : 41 - 42
  • [23] Direct Acting Oral Anticoagulants Following Gastrointestinal Tract Surgery
    Hakeam, A. Hakeam
    Alkhani, Mohammed
    Alyahya, Zyad
    Alawaji, Ziyad
    Ofori, Sandra
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (06) : 867 - 874
  • [24] DIFFERENT CHARACTERISTICS OF GASTROINTESTINAL BLEEDING AMONG DIRECT ORAL ANTICOAGULANTS
    Miyake, Muneaki
    Shimodate, Yuichi
    Mizuno, Motowo
    Takayama, Hiroshi
    Sunami, Tomohiko
    Takezawa, Rio
    Doi, Akira
    Nishimura, Naoyuki
    Mouri, Hirokazu
    Matsueda, Kazuhiro
    Yamamoto, Hiroshi
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB570 - AB570
  • [25] Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
    Serrao, Alessandra
    Malfona, Francesco
    Assanto, Giovanni Manfredi
    Orellana, Maria Gabriela Chavez
    Santoro, Cristina
    Chistolini, Antonio
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 625 - 629
  • [26] Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Hematological Malignancies
    Robinson, Renana
    Spectre, Galia
    Lishner, Michael
    Sharabi, Ofek
    Robinson, Eyal
    Avnery, Orly Hamburger
    Gafter-Gvili, Anat
    Raanani, Pia
    Leader, Avi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S360 - S361
  • [27] Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies
    Alessandra Serrao
    Francesco Malfona
    Giovanni Manfredi Assanto
    Maria Gabriela Chavez Orellana
    Cristina Santoro
    Antonio Chistolini
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 625 - 629
  • [28] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Tiffany Guan
    Arianna Laguna
    Alisha Soares
    Carlo S. Legasto
    Shanna Block
    Ila M. Saunders
    Kathryn Alvarez
    Tiffany Pon
    Nimish Patel
    Anjlee Mahajan
    Angela Lee
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 439 - 446
  • [29] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Guan, Tiffany
    Laguna, Arianna
    Soares, Alisha
    Legasto, Carlo S.
    Block, Shanna
    Saunders, Ila M.
    Alvarez, Kathryn
    Pon, Tiffany
    Patel, Nimish
    Mahajan, Anjlee
    Lee, Angela
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 439 - 446
  • [30] A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban)
    Lv, Meina
    Jiang, Shaojun
    Wu, Tingting
    Huang, Nianxu
    Chen, Xia
    Chen, Chunmei
    Zhang, Jinhua
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (01) : 253 - 260